Integrated toxicology: an effective solution for explaining the “Toxicity” of traditional Chinese medicine

Conflict of interest statement

Boli Zhang is the Editor-in-Chief of this journal. Yue Gao is editorial board members of this journal. None of the other authors declare any conflicts of interest.

Funding

This work was financially supported by the National Nature Science Foundation of China (82304857), Jiangxi Provincial Natural Science Foundation (20224BAB216105, 20232BAB206167), and the National Nature Science Foundation of China (82192910).

Author contributions

Huanhua Xu drafted the manuscript. Wei Zhou and Jianfeng Yi revised the manuscript. Boli Zhang and Yue Gao revised the important intellectual content of this manuscript. All the authors have reviewed and approved the final manuscript.

Ethical approval of studies and informed consent

Not applicable.

Acknowledgments

None.

Data availability

All relevant data are within the manuscript.

References

[1] Huang R, Cai Y, Yang L, et al. Safety of traditional Chinese medicine injection based on spontaneous reporting system from 2014 to 2019 in Hubei Province, China. Sci Rep. 2021;11(1):8875.

[2] Ng AWT, Poon SL, Huang MN, et al. Aristolochic acids and their derivatives are widely implicated in liver cancers in Taiwan and throughout Asia. Sci Transl Med. 2017;9(412):eaan6446.

[3] Gao Y, Li C, Liang AH, et al. Compatibility for toxicity attenuation of toxic traditional Chinese medicine: a review and strategies. Zhongguo Zhong Yao Za Zhi. 2022;47(8):1989-1994.

[4] Shen P, Sun DZ, Zhou W, et al. Research progress in toxicity prediction of traditional Chinese medicines. Chin J Pharmacovigilance. 2023;20(4):473-479.

[5] Xu X, Li GM, Sun C, et al. Research progress on water-soluble alkaloids from Fuzi(附子) and their pharmacological effects. Pharmacol Clin Chin Mater. 2021;37(5):213-219.

[6] Yang X, Xia D, Tian CH, et al. Literature analysis of 508 cases reports of adverse reactions induced by aconiti lateralis radix praeparata. Chin J Pharmacovigilance. 2017;14(10):615-621.

[7] Xiang Y, Guo AX, Zhang SF, et al. Efficacy analysis of compound Huangdai tablets in the treatment of acute promyelocytic leukemia. Chin J Pract Intern Med. 1999;19(10):611-612.

[8] Zhu HH, Hu J, Lo-Coco F, et al. The simpler, the better: oral arsenic for acute promyelocytic leukemia. Blood. 2019;134(7):597-605.

[9] Zhu HH, Wu DP, Jin J, et al. Oral tetra-arsenic tetra-sulfide formula versus intravenous arsenic trioxide as first-line treatment of acute promyelocytic leukemia: a multicenter randomized controlled trial. J Clin Oncol. 2013;31(33):4215-4221.

[10] Wang L, Zhou GB, Liu P, et al. Dissection of mechanisms of Chinese medicinal formula Realgar-Indigo naturalis as an effective treatment for promyelocytic leukemia. Proc Natl Acad Sci U S A. 2008;105(12):4826-4831.

[11] Zhang X, Chen H, Huang X, et al. Single-cell transcriptomics profiling the compatibility mechanism of As2O3-indigo naturalis formula based on bone marrow stroma cells. Biomed Pharmacother. 2022;151:113182.

[12] Xu HH, Ma ZC, Shi QL, et al. Synergistic effect and different toxicities of adjuvant components of Realgar-Indigo Naturalis formula. Chin Herb Med. 2018;10(2):137-144.

[13] Xu HH, Hao FR, Wang MX, et al. Influences of Realgar-Indigo naturalis, a traditional Chinese medicine formula, on the main CYP450 activities in rats using a cocktail method. Evid Based Complement Alternat Med. 2017;2017:2374624.

[14] Jiang Z, Sun Y, Wu Z, et al. Dissection of scientific compatibility of Chinese medicinal formula Realgar-Indigo naturalis as an effective treatment for promyelocytic leukemia from the perspective of toxicology. J Ethnopharmacol. 2023;317:116895.

[15] Shi Z, Gao J, Pan J, et al. A systematic review on the safety of Psoraleae Fructus: potential risks, toxic characteristics, underlying mechanisms and detoxification methods. Chin J Nat Med. 2022;20(11):805-813.

[16] Yang Y, Zhou W, Wang Y, et al. Bavachin induces liver injury and cell apoptosis by targeting Wnt/β-catenin/DRP1 signaling pathway mediated mitochondrial dysfunction. Toxicol Lett. 2023;387:1-13.

[17] Huang CS, Deng HF, Zhou L, et al. Undesirable ER stress induced by bavachin contributed to follicular atresia in zebrafish ovary. Biomed Pharmacother. 2023;166:115322.

[18] Shen P, Bai ZJ, Zhou L, et al. A Scd1-mediated metabolic alteration participates in liver responses to low-dose bavachin. J Pharm Anal. 2023;13(7):806-816.

RIGHTS & PERMISSIONS

Acupuncture and Herbal Medicine